Daiichi apparently declined the offer.
Breast Cancer Hormone Receptor Status.
Manufacturing set-up and a small scale trial are also required before the adapted vaccine might be available in autumn.
We avoid using tertiary references.
AstraZeneca in oncology AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients.
An increased risk of the rare and potentially fatal has been associated with mainly younger female recipients of the vaccine.